Susan M. Catalano

Susan M. Catalano

Keine laufenden Positionen mehr

Vermögen: 166 $ am 31.05.2024

60 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Susan M. Catalano

EinheitArt der EinheitIndustrie
Public Company Biotechnology 14

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Susan M. Catalano

UnternehmenSektorVerknüpfte PersonenHauptposition
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Hank Safferstein

James O'Brien

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Other

Jack Khattar

Chairman

ENZO BIOCHEM, INC. Biotechnology

James O'Brien

Corporate Officer/Principal

Biotechnology

Franz Hefti

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Jack Khattar

Franz Hefti

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Lisa Ricciardi

Director/Board Member

Miscellaneous Commercial Services

James O'Brien

Corporate Officer/Principal

ACORDA THERAPEUTICS, INC. Pharmaceuticals: Major

Hank Safferstein

Anthony Caggiano

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

CHIMERIX, INC. Pharmaceuticals: Major

Lisa Ricciardi

Kenneth Moch

Director/Board Member

Chief Executive Officer

The University of Chicago College/University

Lisa Ricciardi

Anthony Caggiano

Masters Business Admin

Doctorate Degree

George Washington University College/University

James O'Brien

Peggy Wallace

Undergraduate Degree

Undergraduate Degree

The Trustees of Columbia University in The City of New York College/University

Hank Safferstein

Robert J. Gailus

Masters Business Admin

Undergraduate Degree

Pharmaceuticals: Major

Franz Hefti

Director/Board Member

ACUMEN PHARMACEUTICALS, INC. Pharmaceuticals: Major

Franz Hefti

Chief Executive Officer

Biotechnology

Franz Hefti

Chairman

ANNOVIS BIO, INC. Pharmaceuticals: Major

Franz Hefti

Director/Board Member

ALZHEON, INC. Biotechnology

Franz Hefti

Director/Board Member

Pharmaceuticals: Major

Franz Hefti

Chief Executive Officer

Pharmaceuticals: Major

Franz Hefti

Chairman

PREVAIL THERAPEUTICS INC. Biotechnology

Franz Hefti

Chief Executive Officer

Medical/Nursing Services

Franz Hefti

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Franz Hefti

Director/Board Member

Biotechnology

Franz Hefti

Director/Board Member

Investment Managers

Peggy Wallace

Private Equity Investor

Electrical Products

Peggy Wallace

Director/Board Member

College/University

Franz Hefti

Corporate Officer/Principal

Pharmaceuticals: Major

Jack Khattar

Director/Board Member

ADAMAS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Jack Khattar

President

Investment Managers

Jack Khattar

Consultant / Advisor

Miscellaneous Commercial Services

James O'Brien

Comptroller/Controller/Auditor

College/University

James O'Brien

Masters Business Admin

Pharmaceuticals: Major

James O'Brien

Comptroller/Controller/Auditor

College/University

Franz Hefti

Corporate Officer/Principal

ALLERGAN PLC Pharmaceuticals: Major

James O'Brien

Comptroller/Controller/Auditor

Insurance Brokers/Services

James O'Brien

Comptroller/Controller/Auditor

TAKEDA PHARMACEUTICAL COMPANY LIMITED Pharmaceuticals: Major

James O'Brien

Corporate Officer/Principal

FARON PHARMACEUTICALS OY Pharmaceuticals: Major

James O'Brien

Director of Finance/CFO

University of Zurich College/University

Franz Hefti

Doctorate Degree

Pharmaceuticals: Major

Franz Hefti

Director/Board Member

Biotechnology

Franz Hefti

Corporate Officer/Principal

Statistik

International

Vereinigte Staaten 38
Schweiz 4
Kanada 3
Irland 2
Japan 2

Sektoral

Health Technology 29
Consumer Services 8
Finance 6
Commercial Services 4
Health Services 2

Operativ

Director/Board Member 79
Corporate Officer/Principal 59
Independent Dir/Board Member 22
President 21
Chief Executive Officer 17
  1. Börse
  2. Insiders
  3. Susan M. Catalano
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT